The case of the day is In re Application of Biomet Orthopaedics Switzerland GmbH (3d Cir. 2018). It’s an outgrowth of one of the first cases I ever wrote about on Letters Blogatory, Heraeus Kulzer, GmbH v. Biomet, Inc., 633 F.3d 591 (7th Cir. 2011). Time flies. Here was my brief description of the earlier case from way back in January 2011: Hereaus manufactures “bone cement” used in orthopedic surgery. It claimed that in the 1970s, it gave confidential information to Merck, its distributor, to allow Merck to obtain regulatory approvals for its product. In 1998 Merck and Biomet, another bone cement manufacturer, entered a joint venture. Hereaus’s claim was that Biomet had used the relationship with Merck to steal Hereaus’s trade secrets and…